When the first set of prices under the Medicare Drug Price Negotiation Program went into effect, they intersected with the 340B Drug Pricing Program and created the potential for billions of dollars ...
The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved patients by requiring pharmaceutical companies to offer prescription discounts ...
On July 2, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year 2027 Hospital Outpatient Prospective Payment System ...
The CMS proposed a rule on Thursday that would slash Medicare payment rates for a program that hospitals use to buy discounted drugs and implement site-neutral payments for some imaging services next ...
CMS intends a significant drop in reimbursement for 340B drug payment program participants, along with potentially burdensome reporting requirements for non-participants. This article was originally ...
On July 10, the Centers for Medicare & Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (MPFS) proposed rule, which includes proposals related to identification of Medicare ...
Examining the drivers of 340B drug program growth, the impact of vertical integration and contract pharmacies, the ongoing legal and regulatory disputes, and the strategic considerations life sciences ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results